MTEM — Molecular Templates Income Statement
0.000.00%
Last trade - 00:00
- $9.94m
- -$5.87m
- $19.75m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.3 | 22.3 | 18.8 | 38.7 | 19.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 44.3 | 92.7 | 121 | 119 | 109 |
Operating Profit | -31 | -70.4 | -102 | -80.1 | -88.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -30.3 | -69.4 | -105 | -83 | -92.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -30.3 | -69.4 | -105 | -83 | -92.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -30.3 | -69.4 | -105 | -83 | -92.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.3 | -69.4 | -105 | -83 | -92.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -15.3 | -18.8 | -32.4 | -22.5 | -24.6 |